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ABSTRACT 
There is limited information in the literature comparing gait speed among 
individuals who are in the chronic stages of Parkinson’s disease (PD), stroke and 
traumatic brain injury (TBI).  The primary aim of this study was to examine the 
physical functioning of individuals with these chronic neurological conditions over a 
12-month period assessed at baseline (time 1) and six month intervals (time 2, 3).  
This observational research study used descriptive statistics and to describe the 
physical functioning of individuals with PD, stroke and TBI and was part of a 
longitudinal study being conducted over five years to describe communication, dietary 
and physical activity behaviors of adults with neurological diagnoses.  Seven 
community dwelling adults (n=7) between the ages of 34 and 71 years completed the 
evaluations.  The tests used to examine physical function included gait speed, repeated 
chair stands, short physical performance battery (SPPB), timed up and go (TUG), and 
the Physical Activity and Disability Scale (PADS).  The results were analyzed for the 
cohort and divided into two groups for comparison: PD and acquired brain injury 
(ABI).  ABI included people with the TBI and stroke diagnoses.  Changes in gait 
speed were determined using analysis of covariance.  A Pearson’s product moment 
correlation coefficient was used to determine association between gait speed and 
physical function assessments.  Statistical significance was set at p < 0.05.  Analysis 
of covariance (ANCOVA) results showed a statistically significant decrease (i.e. 
improvement) in gait speed (p < 0.03) for the ABI group over 12 months. Although 
not statistically significant, there was also a decrease in gait speed (p < 0.10) for the 
PD group.  The ANCOVA results also showed a statistically significant increase (i.e. 
  
decline) in the TUG test time of 3.33 seconds (p = 0.054) for the ABI group and 
increases in time for the PD group and cohort.  Baseline gait speed for all participants 
correlated with the total SPPB score r = -0.97, p = 0.001) and the TUG test (r = 0.97, p 
= 0.001).  Time 3 gait speed for all participants also correlated with the PADS score (r 
= -0.79, p = 0.06) in addition to the SPPB score (r = -0.87, p < 0.01) and TUG test (r = 
0.96, p < 0.01).  There was a statistically significant decrease in gait speed of adults 
with ABI measured three times in 12 months.  Secondary findings include the 
significant decline in mobility in adults with ABI measured over 12 months.  The 
significant relationship between gait speed and the physical function, mobility and 
physical activity scores was also a secondary finding. Future studies should consider 
interventions aimed at improving physical activity and fall and balance self-efficacy to 
explore the impact on gait speed in chronic neurological conditions.  Future 
longitudinal research should also be conducted with a larger sample size and broader 
range of chronic neurological conditions to allow generalization of the study findings. 
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ABSTRACT 
Background: There is limited information assessing gait speed over time in the 
chronic stages of Parkinson’s disease (PD) and acquired brain injury (ABI).  
Hypothesis: There will be no change in gait speed in adults with chronic neurological 
conditions measured three times over 12 months.   
Methods: An observational research design was used to examine physical functioning 
in seven participants over 12 months.  Physical status was assessed using the short 
physical performance battery (SPPB), timed up and go (TUG), and Physical Activity 
and Disability Scale (PADS).  Cognitive function was examined using the Repeatable 
Battery for the Assessment of Neuropsychological Status (RBANS).  Data were 
analyzed using descriptive statistics, analysis of covariance, and Pearson’s correlation 
coefficients. 
Results:  ANCOVA results showed a decrease in gait speed within the ABI group (p 
< 0.03) and within the PD group (p < 0.10) along with an increase in the TUG time of 
3.33 seconds (p = 0.054) for the ABI group and increases in time for the PD group and 
cohort.  Gait speed at 12 months correlated with the PADS score (r = -0.79, p = 0.06), 
SPPB score (r = -0.87, p < 0.01) and TUG test (r = 0.96, p < 0.01) for the cohort.   
Conclusions: There was a statistically significant improvement in gait speed of adults 
with ABI measured over 12 months.  Secondary findings include 1) a significant 
decline in mobility in adults with ABI and 2) the significant relationship between gait 
speed and the physical function, mobility and physical activity scores.   
Keywords. Parkinson’s disease, traumatic brain injury, stroke, gait speed, physical 
function 
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INTRODUCTION 
Traumatic brain injury (TBI) and stroke affect 1.7 million and 795,000 Americans 
in the United States (US) each year respectively1,2.  At the same time, one million 
people in the US are living with Parkinson’s disease3.  Parkinson’s disease (PD), TBI 
and stroke can result in disabilities that include decreased ability to communicate, 
difficulty maintaining a healthy diet, and reduced levels of physical activity and 
physical function.  The TBI and stroke diagnoses are both considered acquired brain 
injury (ABI). 
Individuals with ABI and PD are particularly vulnerable to the damaging effects 
of physical inactivity and face declines in balance, coordination, strength, mobility and 
overall quality of life4.  Gait speed, coined the sixth vital sign, has been suggested to 
correlate with functional ability and balance confidence and aids in determining 
rehabilitation potential and fall risk5.  Additionally, gait speed improvement has been 
linked to enhanced quality of life5,6 and is critical to maintaining community 
ambulation or independent mobility outside the home7.   
There is limited information in the literature about gait speed in individuals who 
are in the chronic stages of PD and ABI8.  There is even less information that jointly 
examines gait speed in persons with PD or ABI.  Therefore, the primary aim of the 
study was to examine the physical functioning of individuals with chronic 
neurological conditions of stroke and ABI over a 12-month period assessed at six 
month intervals.  Specifically, the null hypothesis was that there will be no change in 
gait speed of adults with chronic neurological conditions measured three times over 12 
months.  Independent predictors of changes in gait speed including the short physical 
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performance battery (SPPB) total score, repeated chair stands, timed up and go (TUG) 
test, Physical Activity and Disability Scale (PADS) score, and Repeatable Battery for 
the Assessment of Neuropsychological Status (RBANS) delayed memory index were 
also explored. 
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METHODOLOGY 
Study Design 
This observational research study used surveys and quantitative evaluations to 
assess the physical functioning of individuals with PD and ABI.  The study lasted 12 
months and consisted of three evaluations: baseline, time 2, and time 3.  The baseline 
measures were collected when the participants joined the study.  Time 2 measures 
were collected at six months and time 3 measures were collected at 12 months.  The 
study was part of an Institutional Review Board (IRB) approved longitudinal study at 
the University of Rhode Island being conducted over five years to describe 
communication, dietary and physical activity behaviors of adults with neurological 
diagnoses (Longitudinal Study of Communication, Nutrition and Physical Activity, 
IRB HU1314-006). 
 
Participants 
The longitudinal study participants were required to be 1) diagnosed with PD, 
TBI or stroke, 2) determined to be medically stable by a neurologist, 3) between the 
ages of 18 and 85 years, and 4) sign an informed consent form.  They were recruited 
equally in an attempt to represent the demographics of Rhode Island.  Rolling 
admission was accomplished through word of mouth and by sending brochures to 
local physicians, hospitals and support groups.  Of the 15 participants currently in the 
study, seven completed three evaluations in the 12-month period of this study.   
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Outcome Measures  
The independent variables in this study were the neurological conditions.  Gait 
speed, a component of the SPPB, was the primary outcome measure.  Changes in other 
measures of physical function including the SPPB score, repeated chair stands, and 
TUG test were examined to determine if there was a relationship or association with 
changes in gait speed.  Dependent variables including the PADS score and RBANS 
delayed memory index were also analyzed to determine if there is a relationship with 
changes in gait speed.  Following is a description of the instruments and techniques 
used to collect these data along with the anthropometric data.       
Physical Functioning Assessment.  The SPPB instrument is widely used to assess 
lower extremity function and takes fewer than ten minutes to complete.  It includes 
using three low participant-burden activities to assess participant’s physical 
functioning: gait speed, standing balance, and time to rise from a chair and return to 
the seated position.  The score range for each subtest is zero to four points with a 
maximum cumulative score of 12 points9, 10.  Each test was timed using a hand held 
stopwatch.   
Gait speed was measured by having the participants walk at their usual pace on a 
measured and taped course.  The distance for this study was four meters and the 
participants began and ended the test in the standing position.  Additional unobstructed 
space was be marked at the end of the walking course and participants were instructed 
to continue walking through the finish line to prevent deceleration in pace.  The test 
was repeated and the faster of the two tests was used in the data analysis9. 
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Participants performed side-by-side, semi-tandem (heel of one foot by big toe of 
other foot) and tandem (feet aligned heel to toe) foot positions for the standing balance 
tests.  They were assisted to the standing position as needed and timed when they were 
standing independently.  The timing ended at 10 seconds or earlier if the participant 
lost balance by moving their feet or grasping for support9.   
Five-time repeated chair stands were performed to test lower extremity strength 
and endurance.  A chair was placed against the wall.  Participants were instructed to 
fold their arms over their chests and attempt one stand.  If successful, participants 
were asked to stand and sit as quickly as possible without the use of their arms for five 
repetitions.  Participants were timed from the point when they arose from the chair, 
stood five times and returned to the seated position9. 
A TUG test was also conducted.  The TUG test is a valid predictor of falls and 
mobility and measures the time in seconds required for an individual to rise from a 
chair, walk a prescribed distance, return and sit down in the chair11.  The TUG test 
used in this study was conducted according to a standardized protocol where 
participants were asked to rise from a chair, walk forward four meters at their usual 
walking pace, turn 180 degrees around a cone, walk four meters back to the chair, and 
finally sit down.  The test was repeated and the better of the two tests was used in the 
data analysis.  The test was timed using a hand held stopwatch.   
Physical Activity and Disability Scale.  The PADS, a self-reported survey, 
provides a reliable and valid measure of physical activity for persons with disabilities 
or chronic health conditions and has been reported to detect intervention related 
changes in physical activity12.  It is composed of six subscales: exercise, leisure time, 
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physical activity, general activity, therapy, employment/school and wheelchair users 
and takes approximately 20 minutes to complete.  The survey is known to discriminate 
between different levels of activity and participants report that it enables them to give 
an accurate description of their level of exercise4.  The participants were interviewed 
to collect the data for the survey.  The scores were calculated using a standardized 
scoring tool. 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). 
The RBANS consists of 12 subtests and takes less than 30 minutes to administer.  It is 
used to measure and yields index scores in immediate and delayed memory, language, 
attention and visuospatial/ constructional abilities.  The results can be used to assess 
cognitive function in individuals from 20-89 years in age13.  This study explored 
whether the delayed memory index is an independent predictor of gait speed in 
individuals with chronic neurologic conditions.  The delayed memory index includes 
four subsets (list recall, list recognition, story recall, and figure recall) that measure 
recall and recognition13.    
Anthropometric measures. The anthropometric measures included height, weight, 
body mass index (BMI) and body composition.  Height and weight were measured 
using a balance beam scale (Detecto, Webb City, MO).  The scale was zeroed prior to 
testing and participants were measured standing erect with their backs to the height 
measuring rod and in bare feet.  The measurements were entered into the formula 
kilograms of body weight divided by height in meters squared (kg/m2) to determine 
BMI. 
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Body composition was measured using a foot to foot bioelectrical impedance 
analysis (BIA) device (Tanita BC-534 Inner Scan Body Composition Monitor, Tanita 
Corporation of America, Inc, Arlington Heights, IL).  The BIA device is a portable 
battery powered foot-to-foot BIA device that resembles a bathroom scale.  It uses a 
very low electrical current to estimate percent body fat14.    Participants were measured 
standing erect with bare feet on the analyzer foot pads.  The individual’s age, gender, 
height, weight, and activity level was entered into the analyzer prior to standing on the 
foot pads.   
 
Statistical Analysis 
A sample size was calculated using SAS statistical software (SAS Institute Inc., 
version 9.2, Cary, NC) and the potential change in gait speed and standard deviation 
were based on previous research15.  The sample size calculations were founded on an 
alpha of 0.05, a power of 80%, expected within group difference of 0.18 m/s for gait 
speed, and a within group standard deviation of 0.12 m/s.  Based on the criteria, the 
one group sample size was approximately six participants.  
Data analyses were conducted using SAS statistical software (SAS Institute Inc., 
version 9.2, Cary, NC) and Microsoft Excel (Microsoft Corporation, version 2013, 
Redmond, WA).  Mean values for demographic and descriptive characteristics were 
calculated for all participants and the PD and ABI groups and are represented as 
continuous variables.  Normality of the data was determined using the Shapiro-Wilk 
test.  An outlier analysis was performed for gait speed using the mean plus or minus 
three standard deviations.  A repeated measures analysis of covariance (ANCOVA) 
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was used to examine changes in gait speed for the cohort and the between the PD and 
ABI groups over the course of the study.  The covariate was the baseline measure for 
each group.  Statistical significance was set at p < 0.05.  Additionally, correlations 
were conducted to quantify the relationship between gait speeds and the SPPB, TUG, 
PADS and RBANS delayed memory index scores.  A Pearson's product moment 
correlation coefficient was calculated to evaluate the relationships16. 
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RESULTS 
The results were reviewed for the cohort and divided into two groups for 
comparison: PD and ABI.  A Shapiro-Wilk test supported the normality of the data at 
baseline (p = 0.28) and time 3 (p = 0.30).  Demographic characteristics, 
anthropometric measures and indicators of physical functioning, physical activity and 
cognitive function for each group are summarized in Table 1.  The participants 
included six males and one female and were between the ages of 34 and 71 years.  The 
mean age for the PD group was 67.5 years and the ABI group was 43 years.  All 
participants were community dwelling adults living with PD or ABI for greater than 
three years.  Four participants were diagnosed with PD and three were diagnosed with 
an ABI.  Of the three ABI participants, one was diagnosed with stroke, one with TBI 
and one was diagnosed with both stroke and TBI.  There were statistically significant 
differences (p < 0.05) between the PD and ABI groups in age, SPPB total, gait speed 
and the TUG test.   
Table 2 displays the changes that occurred from the baseline to the time 3 
measurements in the cohort, PD and ABI groups.  Each of the groups experienced a 
decrease in weight, body fat, BMI and gait speed.  There was also an increase in the 
TUG time and the PADS score for each group.  The total SPPB score increased for the 
ABI and decreased for the cohort and PD groups.  Contributing to this score was the 
decrease in the chair stand time for the ABI group and increase in the cohort and PD 
groups.  The RBANS delayed memory index decreased in the PD group and increased 
in the cohort and ABI group. 
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The ANCOVA results for the gait speed changes are displayed in Table 3.  The 
results showed a statistically significant decrease (i.e. improvement) in gait speed (p = 
0.032) for the ABI group. Although not statistically significant, there was also a 
decrease in gait speed for the PD group (p = 0.099) and cohort.  The difference 
between the groups was not significant.   
The ANCOVA results displayed in Table 4 also showed a statistically significant 
increase (i.e. decline) in the TUG test time of 3.33 seconds (p = 0.054) for the ABI 
group and increases in time for the PD group and cohort.  The difference between the 
groups was not significant.   
Baseline gait speed for all participants correlated with the total SPPB score (r = -
0.97, p < 0.001) and the TUG test (r = 0.97, p < 0.001).   No significant correlation 
was found between baseline gait speed and the chair stands, PADS score, or RBANS 
Delayed Memory Index.  Time 3 gait speed for all participants also correlated with the 
PADS score (r = -0.79, p = 0.06) in addition to the SPPB score (r = -0.87, p < 0.01) 
and TUG test (r = 0.96, p < 0.01).   
Baseline, time 2 and time 3 performance measures for each participant are 
reported in Table 7.  Each participant attended the three evaluations; however, two 
participants were not able to complete the repeated chair stands, one participant was 
not able to complete the TUG test, and one participant did not complete the PADS 
instrument.   
Physical functioning (SPPB) 
Baseline SPPB scores ranged from 5 - 11.  At time 3, three of the participants 
increased their score, one remained the same and three participants had a lower score.  
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The total score was lowest for the two participants that could not complete the 
repeated chair stands. 
Gait Speed 
Baseline gait speeds for the four meter test ranged from 4.16 to 9.68 seconds or 
0.41 to 0.96 m/s.  All of the participants demonstrated an increase in the m/s; however, 
six of the seven participants demonstrated a meaningful change that ranged from 0.11 
to 0.48 m/s.     
Lower Extremity Performance (Repeated Chair Stands) 
Two participants were unable to complete the repeated chair stands and two 
participants increased the time required to complete the test suggesting a decline in 
lower extremity performance.  Three of the participants decreased the time that they 
required to complete the repeated chair stands. 
Mobility (TUG Test) 
Baseline scores for the TUG test ranged from 8.16 seconds to 18.31 seconds or 
1.02 to 2.29 seconds per meter respectively.  One participant was unable to complete 
the test at time 3, one participant experienced a minimal decrease in score and the 
remaining five participants demonstrated an increase in the time needed to complete 
the test.   
Physical Activity (PADS) 
Four of the seven participants improved from their baseline PADS score during 
the course of the study.  One participant did not complete the survey at time 3; 
however, the participant did show improvement at time 2.  Baseline scores ranged 
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from 26.4 to 310.9.  Scores at time 3 ranged from -21 to 302.2 with a variable change 
of -6 to 705%.    
Recall and Recognition (RBANS Delayed Memory Index) 
The RBANS scores ranged from 40 to 102 at baseline with a variable change of -
8 to 21% at the time 3 evaluation.  No correlation was observed between gait speed 
and the delayed memory index in the cohort. 
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DISCUSSION 
To our knowledge, this is the first study to compare gait speed in adults with PD 
and ABI in the chronic stages of recovery.  The primary finding of the study rejects 
the null hypothesis that there will be no change in gait speed of adults with chronic 
neurological conditions measured three times in 12 months.  The results indicated that 
there was a decrease (i.e. improvement) in gait speed in adults with chronic 
neurological conditions and statistically significant improvements in participants with 
ABI measured three times in 12 months.  
The time required to complete the 4-m gait speed test improved for the ABI group 
by 2.53 seconds (p = 0.03) and for the PD group by 0.85 seconds (p = 0.10).  Although 
not statistically significant, the time also improved for the cohort by 1.57 seconds (p = 
0.38).  The improvement in walking speed was 0.17 m/s for the PD group, 0.26 m/s 
for the ABI group and 0.23 m/s for the cohort.  The improvements exceed the 
minimally meaningful change for the 4-m gait speed test has been reported by Kwon 
et al. as 0.03-0.05 m/s17 suggesting that the improvements experienced by the study 
cohort may have important implications in community ambulation.   
Gait speed has been reported to be the most efficient predictor of household and 
community ambulation, a significant determinant of community ambulation, and a 
powerful indicator of function and prognosis post-stroke18-20.  The gait speed cut-off 
points for community ambulation have been reported in several articles and range 
from 0.66 m/s for community ambulation19 to 0.8 m/s for full community 
ambulation20.  The gait speed for the each of the groups exceeded the cut-off point of 
0.66 m/s and the threshold for full community ambulation (Cohort 0.90 m/s, PD 1.0 
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m/s, ABI 0.8 m/s) at the time 3 evaluation.  The individual scores ranged from 0.66 
m/s to 1.08 m/s for the participants with PD and 0.63 to 0.92 m/s for the participants 
with ABI.   
Although gait speed improved for all participants, the time required to complete 
the mobility test increased resulting in a performance decline for each of the groups 
and participants.  The TUG times in m/s for the cohort, PD and ABI groups equated to 
0.55 m/s, 0.76 m/s, and 0.43 m/s, respectively.  This may have resulted from the 180 
degree turn in the TUG and deficits in balance, coordination and self-efficacy that are 
experienced by individuals with chronic neurological conditions.  The declines are 
consistent with a longitudinal study by van de Port et al.21 that suggested that mobility 
is not stable, but time dependent with approximately 20 percent of the participants 
experiencing decreased mobility from one to three years post-stroke21.  They are also 
similar to a study where individuals with chronic TBI were found to exceed the MDC 
for walking speed with smaller gains in the TUG test.  Gains that were maintained at 
the three month post intervention were attributed to improvements in gait speed, 
mobility, balance and fall self-efficacy22. 
The mean ages of the PD and ABI groups were also considered as confounding 
variables on the gait speed and mobility results.  The mean age for the PD group was 
24.5 years greater than the mean age of the ABI group.  Thus, this could have had an 
effect on these results as the aging process is accompanied by sarcopenia or a gradual 
loss of skeletal muscle mass and function that typically begins after age 30 that is 
associated with worsened physical functioning23.  In a three year study by Trombetti et 
al.24, participants with age-associated declines in muscle mass, strength, power and 
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physical performance were found to have decreased SPPB scores and increased walk 
times24.  The PD group (mean age 67.5, SD 3.8) had higher scores on the SPPB and 
walked faster than the ABI group (mean age 43, SD 13) over the course of the study.  
However, the ABI group exhibited greater improvements in their SPPB scores and 
walking speed at time 3 possibly due to their younger age. 
Major findings of the study also included the statistically significant relationship 
identified between gait speed at baseline and time 3, and the total SPPB score and 
TUG test for all participants.  At time 3, there was also significant correlation PADS 
score.  The PADS has been reported to detect changes in physical activity in persons 
with disabilities and chronic health conditions12.  There was an increase in the PADS 
score for each group.  Although this study did not involve an intervention, the majority 
of the participants were engaged in physical therapy, occupational therapy or physical 
training and an increase in physical activity was reported via the PADS interview for 
five of the seven participants.  The increase in physical activity may have contributed 
to the previously mentioned improvement in gait speed times, but this is merely 
speculative. 
A study by Duff et al.25 reported significant partial correlations (p < 0.01) 
controlling for age, gender and education between gait times and the RBANS total 
score and component indexes (total r = -0.25, immediate memory r = -0.20, 
visuospatial/constructional r = -0.18, language r = -0.12, attention r = -0.21, delayed 
memory r = -0.15)25.  A recent study reported that poorer short term memory assessed 
using a 10 word recall test (immediate and delayed recall) was associated with slower 
gait speed in community dwelling individuals 50 years and older26.  However, no 
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correlation was observed between gait speed and the RBANS delayed memory index 
in the cohort. 
The SPPB was established by Guralnik et al. as a disability measure for older 
adults9.  In 2010, Vazzana et al.27 defined impaired mobility as a SPPB score of less 
than 1027.  The component tests provide an indication of physical function including 
gait speed, balance and lower extremity performance.  All total scores for the cohort 
and PD and ABI groups were 10 or less suggesting impaired mobility.  The scores 
ranged from 8.0 to 8.8 at time 3 with the total SPPB score increasing for the ABI 
group and decreasing for the cohort and PD groups.  Contributing to the scores was 
the improvement in the repeated chair stand time for the ABI group and decline in the 
cohort and PD groups.  A minimally meaningful change for the SPPB has been 
reported by Kwon et al. as 0.3 – 0.8 points17.  The total SPPB score improved 
clinically for the ABI group by 1.3 points for a mean total score of 8.0.  The score 
declined for the PD group by 1.2 points and the cohort by 0.2 points for mean total 
scores of 8.8 and 8.4, respectively.   
The longitudinal findings of this study are an improvement to the existing 
knowledge and will contribute to identifying the natural progression of disability in 
the PD and ABI populations.  Limited longitudinal studies are available in the 
literature that evaluated physical functioning in chronic neurological conditions and 
those found primarily concern the stroke population.  For example, a longitudinal 
study by van de Port et al.21 focused on deterioration of mobility from one to three 
years post-stroke used a self-reported mobility index consisting of 14 questions and 
one observation to assess mobility21.  The present study used objective performance 
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measures to assess gait and mobility.  Peters et al.22, studied balance, mobility and gait 
speed in individuals with chronic TBI.  The study involved task specific training to 
address balance, gait, strength and coordination.  Evaluations were performed at 
baseline, after 10 exercise sessions and 20 exercise sessions.  A follow up evaluation 
was performed at three months and the gait speed and mobility gains were maintained 
by the participants22; however, no further evaluations were conducted.   
Limitations of the study included the small sample size, multiple examiners, the 
participants being exposed to different medical interventions during the study 
(physical therapy, occupational therapy, physical training) and the effects of repeated 
testing.  The small sample size limited the ability to detect statistical significance and 
the generalizability of the results to individuals with PD, TBI and stroke.  Although 
there were multiple examiners, a study strength included using defined protocols and 
trained observers for each of the tests.  For the self-reported physical activity survey, 
interviews were used to obtain the information and the examiner was able to rephrase 
questions or ask additional questions to clarify responses.  As part of this survey, 
information was also collected on the time each participant spent in therapy or 
physical training and the activities that resulted in an increased PADS score.  Repeated 
testing could be also be seen as a threat to internal validity as individuals become 
familiar with the test items and perform better on subsequent tests; however, periodic 
evaluations over time were also a strength of the 12-month study28. 
The key barriers to adopting physical activity include self-efficacy; fear of falling; 
and disability, balance and environmental concerns29-32.  Although not examined in 
this study, evaluating these behaviors in future research may provide additional insight 
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into the barriers that result in reduced levels of physical activity in the PD, TBI and 
stroke populations.  Additionally, future research should expand recruitment across the 
three conditions, to compare differences between PD, TBI and stroke, rather than just 
PD and ABI.  Future longitudinal studies should consider adding an intervention 
designed to ameliorate gait speed, mobility and self-efficacy and monitor the long 
term changes in physical function. 
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CONCLUSIONS 
In summary, this is the first study to compare gait speed in adults with PD and 
ABI in the chronic stages of recovery.  The results indicated that there was a 
statistically significant improvement in gait speed of adults with ABI over the 12-
month period studied.  Secondary findings included the significant decline in mobility 
in adults with ABI measured three times in 12 months and the relationship between 
gait speed and the physical function, mobility and physical activity scores.  Future 
studies should consider interventions aimed at improving physical activity and fall and 
balance self-efficacy to explore the impact on gait speed in chronic neurological 
conditions.  Future longitudinal research should be conducted with a larger sample 
size and broader range of chronic neurological conditions to verify the study findings.  
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TABLES 
Table 1: Baseline Characteristics of the Cohort and PD and ABI groups. 
  
 
All (n=7) PD (n=4) ABI (n=3) P-value 
Age (years) 57.0 (15) 67.5 (3.8) 43.0 (13) 0.015 
Months Elapsed 128.4 (80.7) 80.8 (57) 192 (63.5) 0.059 
Gender 
   
0.429 
   Men 6 4 2  
   Women 1 0 1  
Height (cm) 173.7 (7.1) 172.4 (6.6) 175.5 (8.8) 0.615 
Weight (kg) 81.8 (11.4) 80.6 (11.9) 83.4 (13.0) 0.783 
Body Fat (%) 28.0 (5.6) 26.7 (3.4) 30.7 (10.0) 0.466 
BMI (kg/m2) 27.0 (2.1) 27 (2.7) 26.9 (1.6) 0.960 
SPPB (total points) 8.6 (2.1) 10 (.82) 6.7 (1.5) 0.013 
SPPB Gait Speed 
(seconds) 
6.0 (2.0) 4.8 (.88) 7.6 (2.0) 0.050 
SPPB Chair Stand 
(seconds) 
13.2 (2.0) 13.4 (2.44) 12.9 (0.9) 0.812 
TUG Test (seconds) 12.4 (3.7) 10.1 (1.8) 15.4 (3.5) 0.045 
PADS score 117.3 (95.0) 
137.6 
(118.2) 
90.2 (64.6) 0.563 
RBANS Delayed 
Memory score 
74 (27.0) 75 (31.9) 72.7 (25.8) 0.922 
 
All data are expressed as means with (standard deviations).  Exception – gender 
P-value was calculated using an unpaired t-test and represents the between PD and 
ABI group differences. P-value for gender was calculated using a Fisher’s Exact Test.  
 
SPPB (4m walk, balance, repeated chair stands) - physical function 
SPPB Gait Speed – 4 meter walk measured in seconds 
SPPB Chair Stand - repeated chair stands measured in seconds 
TUG Test – 8 meter mobility test measured in seconds 
PADS score - physical activity level 
RBANS delayed memory index (list recall, list recognition, story recall, and figure 
recall) - recall and recognition   
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Table 2: Baseline, Time 2, Time 3 Data and Change in the Cohort and PD and ABI 
Groups 
 
Dependent Variable All (n=7) PD (n=4) ABI (n=3) P-value 
SPPB (total points) 
Baseline 8.6 10.0 6.7 0.013 
Time 2 8.7 9.8 7.3  
Time 3 8.4 8.8 8.0 0.786 
Change -2% -12% 19%  
SPPB Gait Speed (seconds) 
Baseline 6.0 4.8 7.6 0.050 
Time 2 4.8 3.6 6.3  
Time 3 4.5 4.0 5.1 0.325 
Change -25% -17% -33%  
SPPB Chair Stand (seconds) 
Baseline 13.2 13.4 12.9 0.812 
Time 2 14.6 12.5 16.6  
Time 3 13.3 14.2 12.0 0.484 
Change 1% 6% -7%  
TUG Test (seconds) 
Baseline 12.4 10.1 15.4 0.045 
Time 2 14.8 11.0 19.8  
Time 3 14.6 10.5 18.7 0.013 
Change 18% 4% 21%  
PADS (total points) 
Baseline 117.3 137.6 90.2 0.563 
Time 2 120.8 129.3 109.6  
Time 3 168.6 140.0 197.1 0.636 
Change 44% 2% 119%  
RBANS Delayed Memory Index 
Baseline 74.0 75.0 72.7 0.922 
Time 2 81.9 87.3 74.7  
Time 3 76.3 74.0 79.3 0.828 
Change 3% -1% 9%  
All outcome variable data are expressed as means.  P-value was calculated using an 
unpaired t-test and represents the between PD and ABI group differences.  
SPPB (4m walk, balance, repeated chair stands) - physical function 
SPPB Gait Speed – 4 meter walk measured in seconds 
SPPB Chair Stand - repeated chair stands measured in seconds 
TUG Test – 8 meter mobility test measured in seconds 
PADS score - physical activity level 
RBANS delayed memory index (list recall, list recognition, story recall, and figure 
recall) - recall and recognition  
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Table 3: Gait Speed Time Changes Within Cohort, PD and ABI Groups and Between 
PD and ABI Groups 
 
Gait Speed (seconds) Mean Change Std Dev P-value 
Within All -1.57 1.19 0.384 
Within PD -0.85 0.76 0.100 
Within ABI -2.53 0.97 0.032* 
Between PD & ABI 
  
0.384 
*Significant at p < 0.05 
SPPB Gait Speed – 4m walk measured in seconds 
 
Table 4: TUG Changes Within Cohort, PD and ABI Groups and Between PD and 
ABI Groups 
 
TUG (seconds) Mean Change Std Dev P-value 
Within All 2.21 1.91 0.190 
Within PD 1.10 1.01 0.876 
Within ABI 3.33 2.09 0.054* 
Between PD & ABI 
  
0.190 
*Significant at p = 0.05 
TUG Test - 8m mobility test measured in seconds 
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Table 5: Baseline, Time 2, Time 3 Data and Change for each Participant 
 
Outcome Measures Baseline Time 2 Time 3 Change 
SPPB Score 
Participant 1 9 7 4 -56% 
Participant 2 10 10 9 -10% 
Participant 3 10 10 11 10% 
Participant 4 11 12 11 0% 
Participant 5 8 8 9 13% 
Participant 6 7 9 11 57% 
Participant 7 5 5 4 -20% 
Gait Speed 
Participant 1 6.09 4.08 6.05 -1% 
Participant 2 4.3 2.87 3.14 -27% 
Participant 3 4.78 3.34 3.04 -36% 
Participant 4 4.16 4.22 3.72 -11% 
Participant 5 5.81 5.19 4.37 -25% 
Participant 6 7.31 5.83 4.48 -39% 
Participant 7 9.68 7.89 6.37 -34% 
SPPB Chair Stands 
Participant 1 10.47 N/A N/A 
 
Participant 2 14.31 14.93 18.19 27% 
Participant 3 16.16 12.09 12.27 -24% 
Participant 4 12.46 10.46 12 -4% 
Participant 5 13.5 10.16 11.16 -17% 
Participant 6 12.25 13.41 12.87 5% 
Participant 7 N/A 26.29 N/A 
 
TUG test 
Participant 1 12.22 13.48 N/A 
 
Participant 2 8.16 9.71 9.93 22% 
Participant 3 10.79 9.91 10.72 -1% 
Participant 4 9.16 11.06 10.75 17% 
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Participant 5 11.5 15.03 16.3 42% 
Participant 6 16.43 17.12 17.37 6% 
Participant 7 18.31 27.36 22.56 23% 
PADS Score 
Participant 1 46.5 22.8 -21 -145% 
Participant 2 310.9 176.6 291.9 -6% 
Participant 3 86 161.7 N/A 
 
Participant 4 107.1 156 149.1 39% 
Participant 5 155.6 137.6 302.2 94% 
Participant 6 26.4 165.5 212.4 705% 
Participant 7 88.5 25.6 76.7 -13% 
RBANS Delayed Memory Index 
Participant 1 40 60 44 10% 
Participant 2 102 112 106 4% 
Participant 3 56 75 52 -7% 
Participant 4 102 102 94 -8% 
Participant 5 94 97 97 3% 
Participant 6 44 44 44 0% 
Participant 7 80 83 97 21% 
 
SPPB (4m walk, balance, repeated chair stands) - physical function 
SPPB Gait Speed – 4 meter walk measured in seconds 
SPPB Chair Stand - repeated chair stands measured in seconds 
TUG Test – 8 meter mobility test measured in seconds 
PADS score - physical activity level 
RBANS delayed memory index (list recall, list recognition, story recall, and figure 
recall) - recall and recognition   
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APPENDICES 
Appendix A: Review of the Literature 
Introduction 
Traumatic brain injury (TBI) and stroke affect 1.7 million and 795,000 Americans 
each year respectively1, 2.  At the same time, approximately one million people in the 
United States are living with Parkinson’s disease3.  Parkinson’s disease (PD), TBI and 
stroke disabilities include decreased ability to communicate, difficulty maintaining a 
healthy diet, and reduced levels of physical activity and physical function.  However, 
limited longitudinal data exist on these behaviors beyond the acute phases of recovery 
and in the chronic phases of rehabilitation4. 
The purpose of this literature review is to describe the epidemiology of PD, TBI 
and stroke and their association with physical function, specifically gait speed, in the 
chronic stages of the diseases.  The report will also review current research that 
examined gait speed as a measure of physical performance and function in these 
populations.  
 
Parkinson’s Disease 
Parkinson's disease is a chronic and progressive movement disorder that worsens 
over time and affects two percent of individuals age 60 years and older5.  Older males 
have a higher risk of developing PD6.  The prevalence and incidence increases with 
age and peaks after 80 years of age. The male to female ratio for disease is 
approximately 3:27.  Family history has also been found to be a strong predictor5.  
Ethnicity is a risk factor with Hispanics having the highest risk followed by non-
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Hispanic whites, Asians and Blacks7.  With the aging of the population, a 50 percent 
increase in adults with the disease is expected by 20307.   
The cause of PD is not completely understood and there is presently no cure3.  
The condition likely results from the attrition of dopamine producing neurons that 
regulate motor function, genetics or environmental exposures5.  Loss of dopaminergic 
neurons within the substantia nigra pars compacta (SNpc) has been noted to be the key 
pathological feature in PD7.  There is a 9-13 percent loss of these neurons for every 10 
years of life and 70-80 percent of these neurons are lost before the first symptoms 
appear5.  Lewy pathology is another characteristic of PD.  Lewy bodies in surviving 
SNpc neurons appear to have causal roles in neuronal loss in PD.  Neuroinflammation 
is another characteristic; however, the whether neuroinflammation promotes or 
protects from neurodegeneration has yet to be determined.  Genetics also plays a role 
in PD factors and multiple genes have associated with PD based on mutations 
identified as causes of familial PD7.  
Precipitating factors include a history of mild to moderate head injury, beta-
blocker use and exposure to toxicants including the herbicide paraquat6, 7.  Factors 
associated with a decreased risk for developing the disease include physical activity, 
non-steroidal anti-inflammatory drug use, calcium channel blocker use, alcohol 
consumption and protective genetic factors.  Smoking and coffee consumption have 
also been reported to be lower in adults who develop PD.  Smoking may be reduced 
due to the decreased response to nicotine during early PD6, 7. 
Individuals with PD experience motor symptoms including resting tremors, 
rigidity, hypokinesia, bradykinesia and postural instability.  Secondary symptoms 
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include stooped posture; impaired coordination; decreased cognition, attention, 
executive function, memory; dementia; sleep disorders; sensory changes; speech 
problems; and difficulty swallowing3.  Progression of PD is characterized by 
worsening of the motor symptoms.  In the late stages of the disease, treatment resistant 
motor and non-motor characteristics including postural instability, freezing of gait, 
falls, dysphagia and speech dysfunction become prominent.  Eighty percent of adults 
with the disease are reported to have freezing of gait and falls and 50 percent choking 
after 17 years of disease.  Dementia is reported in 83 percent of adults after 20 years of 
disease duration7.  Older age at the onset the disease has been associated with faster 
rates of motor progression and mortality.  Early onset may increase the risk for 
dystonia6. 
Clinical diagnosis of PD is based on the presence of parkinsonian motor features 
and absence of other diseases that cause Parkinsonism.  Diagnostic tests for definitive 
diagnosis in the early stages of the disease do not exist.  The presence of moderate to 
severe SNpc degeneration and Lewy pathology at the post mortem exam is the current 
gold standard for diagnosis7. 
Therapies for PD treat the symptoms and not the underlying causes of PD.  The 
goals of pharmacological treatments are to improve function and quality of life and 
should be started at diagnosis.  Treatment for motor symptoms include dopamine 
replacement and dopamine agonists.  The medications include levodopa, dopamine 
agonists, monoamine oxidase type B inhibitors and amantadine.  Non-motor 
treatments are condition specific and are often have a limited response7.   
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Deep brain stimulation is also effective in treating tremors and motor symptoms 
moderate to severe PD.  This surgical treatment is implicated in cases where motor 
symptoms respond to levodopa but motor fluctuations and dyskinesia become 
disabling.  The treatment can also improve non-motor fluctuations in sleep-related 
symptoms and behavioral abnormalities and is usually performed 10-13 years after 
diagnosis7. 
Treatments including the introduction of dopamine agonist and dopamine 
replacement therapy are frequently based on change of functional status.  Changes in 
functional status and disability are commonly assessed through surveys or physical 
functioning assessment8.  Gait impairment is a common finding in individuals 
diagnosed with PD and is characterized by decreased gait speed, shortened steps, 
stooped posture and reduced arm swing9, 10.  It is a common focus of pharmacological, 
behavioral and surgical intervention and gait speed has been singled out as a measure 
due to its relevance to community independence and predictive value for important 
health outcomes and mortality10.   
Haas et al.10 studied the minimal clinically important difference (MCID) for gait 
speed in adults in various stages of PD.  Data for the study were collected on 324 
individuals currently receiving pharmacological treatment for their PD symptoms.  
Sixty seven percent of the participants were male.  The average age of the cohort was 
68 with a standard deviation (SD) of 10.  The time since diagnosis averaged 8 years 
(SD 6).  The methods used to measure gait speed included the 5.8 x 0.9 meter (m) 
GAITRite instrument walkway system.  The participants performed four walking trials 
at a comfortable pace.  The course started 1.5-m before the walkway and ended 1.5-m 
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after the walkway to minimize acceleration and deceleration effects.  None of the 
participants used assistive devices and in the event of a freezing episode additional 
walks were performed.  Cross sectional analysis of the clinically important differences 
for gait speed was completed using disability (Schwab and England Activities of Daily 
Living Scale), disease stage (Modified Hoehn and Yahr Scale (H&Y)) and severity 
(Unified Parkinson’s Disease Rating Scale (UPDRS)) distribution and anchor based 
approaches.  The distribution measures relied on the distribution of scores as in the 
minimal detectable change (MDC) and effect size and anchor approaches relied on 
responsiveness to independent measures.  The magnitude of effect for the distribution 
approach was based on the Cohen effect size recommendations of 0.2 as small, 0.5 as 
moderate and 0.8 as large.  The average gait speed was 0.98 m/s with a range of 0.22 – 
1.73 m/s (SD 0.27 m/s).  Using distribution based analysis, the MCID ranged from 
0.05 m/s to 0.22 m/s.  Whereas, the MCID ranged from 0.02 m/s to 0.15 m/s through 
the use of anchor based metrics.  A key limitation of the study was using only short, 
straight walking distance that is not reflective of community ambulation.  The results 
of the study will serve as a tool for evaluating intervention effectiveness and 
benchmarking treatment effects for individuals with PD on medication10. 
A study by Tanji et al.8 compared physical performance measures for their ability 
to discriminate between levels of disability and disease severity in PD.  The cohort 
included 79 individuals age 65.5 (SD 10.6) years with PD.  The participants were 
tested with seven physical performance measures including the Physical Performance 
Test (PPT), modified PPT (mPPT), SPPB, Performance Test of Activities of Daily 
Living (PADL), Berg Balance Scale (BBS), TUG test and Functional Reach (FR).  
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Disability was assessed using the Older Americans Resource and Services and 
Disability Subscale (OARS) and severity was assessed using the UPDRS.  The 
participants were divided into quartiles based on their OARS and UPDRS ratings.  All 
seven measures discriminated across the quartiles of the total severity ratings (PPT, 
mPPT, BBS, TUG, FR: p < 0.01; SPPB, PADL: p < 0.05) and four measures 
discriminated across the disability ratings (PPT, mPPT, BBS, TUG: p < 0.05).  All of 
the measures were more strongly associated with severity than disability and declined 
as the participants moved to worsening stages of severity.  The SPPB, BBS and TUG 
correlated significantly with both disability (SPPB r = 0.41 – 0.56, p < 0.05; BBS r = 
0.55 – 0.60, p < 0.01; TUG r = 0.37 – 0.58, p < 0.05) and severity (SPPB r = 0.56 – 
0.59, p < 0.01; BBS r = 0.59 – 0.74, p < 0.01; TUG r = 0.52 – 0.67, p < 0.01) 
measures.  The FR correlated significantly only with the severity (r = 0.45 – 0.69, p < 
0.05) measures.  The results indicated that the performance measures were more 
sensitive to severity than disability.  However, none of measures consistently 
discriminated between levels of PD severity or disability. The investigators concluded 
that assessment of interventions aimed at gait and balance are enhanced by assessing 
functional measures including the SPPB, TUG, BBS and FR.  In addition, the SPPB, 
TUG and FR require only one to seven minutes to administer and are the best options 
for busy clinical practices where time and ease of administration are critical8. 
Factors associated with exercise behaviors in individuals with PD were examined 
in a cross sectional study by Ellis et al11.  There were 260 participants, age 40 years or 
greater, classified at H&Y stage 1-4 and receiving pharmacological treatments in the 
study.  The Stages of Readiness to Exercise Questionnaire was used to designate 
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participants as exercisers or non-exercisers.  The Physical Activity Scale for the 
Elderly (PASE) along with an activity monitor were used to validate exercise status.  
The factors assessed included measures of body structure and function; activity; 
participation; and environmental and personal factors.  The measures used to quantify 
factors associated with physical activity included the UPDRS (two groups - low 
severity score <40; high severity score > 40), Geriatric Depression Scale (GPS), 6 
minute walk test, Parkinson’s Disease Questionnaire-39 (participation), Self-Efficacy 
for Exercise (SEE) and personal and environmental factors.  Sixty three percent of the 
participants were found to be exercisers.  They had significantly lower UPDRS motor 
scores (p < 0.02), less depression (p < 0.00), less restrictions in participation (p < 
0.001), higher self efficacy (p < 0.001) and higher education (p < 0.00) than the non-
exercisers.  Self efficacy (p < 0.05) and education level (p < 0.05) were more strongly 
associated with exercise behavior than disease severity, activity limitations or 
restrictions in participation.  Limitations of the study included using the self-
administered PASE to validate exercise behavior.  The results suggested self efficacy 
and the confidence to face barriers to exercise as a potential target for intervention11. 
Individuals with PD may have difficulty walking outside the home environment 
due to terrain characteristics, time constraints, walking distance and fluctuations in 
impairment.  Gait speed is one aspect of community walking and was compared with 
demographic characteristics and clinical variables in a cross sectional study by Elbers 
et al.12.  The aim of the study was to examine if comfortable gait speed was a valid 
measure to predict community walking in adults with PD on medication.  Participants 
were excluded if they undergone deep brain stimulation or experienced cognitive 
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impairment.  The cohort consisted of 153 participants with a mean age of 67 years (SD 
7.54) diagnosed with PD.  The evaluations were in the participants’ homes 
approximately one hour after taking medications.  The Nottingham Extended 
Activities of Daily Index was used to identify community walkers.  Seventy or 46 
percent of the participants were classified as community walkers.  Gait speed was 
measured with the 10-m walk test repeated three times.  A minimum distance of 6-m 
was used to adapt to constraints in the participants’ homes.  The time was converted to 
m/s and the mean gait speed was 0.84 m/s (SD 0.20).  The investigators established 
0.88 seconds as a cut off value to discriminate between non-community and 
community walkers.  A receiver operating characteristic curve was constructed to 
investigate the diagnostic accuracy of gait speed as a predictor for community walking 
and showed that a cut-off point of 0.88 m/s correctly classified 70 percent of the 
participants as community walkers and 72 percent as non-community walkers.  
Multivariate regression analysis was also performed to evaluate the added value of 
demographic and clinical variables in predicting community walking.  Fear of falling 
was found to have an added value in predicting community walking.  Study limitations 
included conducting the gait speed test in the participants’ homes and modifying the 
distance from 6-10 meters.  The results indicated that timed walking tests are valid 
measures of community walking and that individuals who experience less fear of 
falling are more likely to be community walkers12. 
In summary, the articles reviewed provided study results concerning physical 
performance measures, clinically important differences in gait speed, community 
walking values and barriers to adopting physical activity among persons with PD.  
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Interventions assessing gait speed, where ease of administration and time are factors, 
will be enhanced by using the SPPB, TUG and FR8.  The clinically important 
difference in gait speed ranged from 0.05 m/s to 0.22 m/s by distribution based 
analysis and 0.02 m/s to 0.18 m/s by anchor based analysis10.  Timed gait speeds tests 
were reported to be valid measures to predict community walking and the 
recommended cut-off value is 0.88 m/s12.  Finally, self-efficacy and fear of falling are 
behaviors that contribute to physical activity in individuals with PD11, 12.  The data in 
each of the studies was from a cross sectional cohort rather than a longitudinal 
evaluation.  
 
Acquired Brain Injury - Stroke 
Acquired brain injury (ABI) is structural damage to the head after birth and 
includes cerebrovascular accidents and TBI13.  A cerebrovascular accident or stroke 
occurs when a vessel in the brain is occluded or ruptures and is the fifth leading cause 
of death and a leading cause of preventable disability in the United States (U.S.)14, 15.  
An occluded vessel in brain results in an ischemic stroke whereas a blood vessel 
rupturing results in a hemorrhagic stroke.  Ischemic strokes account for 87 percent of 
all strokes, and there is also a condition resulting from a temporary occlusion termed 
transient ischemic attack (TIA) that produces stroke like symptoms but no lasting 
damage14. 
An estimated 6.8 million Americans over the age of 20 have experienced a stroke.  
The overall prevalence is 2.8 percent for this population2.  Over the past 10 years, the 
actual number of stroke deaths declined by 21.2 percent, but approximately 795,000 
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individuals continue to experience an ischemic or hemorrhagic stroke annually.  The 
decline in stroke mortality is attributed to the improvement in population health and 
concurrent with the interventions to control cardiovascular risk factors.  The 
hypertension control efforts appear to have the most influence along with control of 
diabetes mellitus and hyperlipidemia, and smoking cessation16.  
The disease is seen primarily in adults over age 65, African Americans and 
people living in the southeastern United States and is a major cause of long term 
disability2, 13.  African-Americans have nearly twice the risk for a first stroke than 
Caucasians and a much higher death rate from stroke.  This is attributed to the higher 
risk of higher risk of high blood pressure, diabetes and obesity found in African 
Americans.  Females have more strokes than men with approximately 60 percent of 
the stroke deaths occurring in women.  Hormonal therapy used to prevent pregnancies 
and increase estrogen levels in postmenopausal women, pregnancy, a history of 
preeclampsia/eclampsia or gestational diabetes, and smoking increase the risks for 
women.  Heredity also plays a key role with stroke risk increasing if grandparents, 
parents or siblings have experienced a stroke.  Strokes may also be symptoms of 
inherited genetic disorders including Cerebral Autosomal Dominate Arteriopathy with 
Sub-Cortical Infarct and Leukoencephalopathy (CADASIL).  Finally, individuals who 
have experienced a stroke are at a higher risk for additional strokes14. 
The primary risk factors for stroke include hypertension, diabetes mellitus, 
hyperlipidemia, atrial fibrillation, smoking, heredity and physical inactivity2, 14.  The 
American Stroke Association has identified hypertension as the leading cause of 
stroke and also described the following risk factors.   
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 Diabetes mellitus is an independent risk factor and is also associated with high 
blood pressure, hyperlipidemia and obesity.   
 Hyperlipidemia can lead to atherosclerosis or the build-up of plaque in the 
arteries resulting in narrowing of arterial walls and the risk for plaques breaking 
open, bleeding and forming emboli.   
 Atrial fibrillation can let blood pool and coagulate in the atrium and result in an 
embolus raising the risk for a stroke.   
 The nicotine and carbon monoxide associated with smoking cigarette damages 
the cardiovascular system and leads to dyslipidemia, hypertension, damaged 
endothelial cells, clotting of platelets and a decreased tolerance for exercise.   
 Physical inactivity can increase the risk for hypertension, diabetes, heart disease 
and stroke14. 
Stroke prevention involves managing the enabling factors listed above.  
Pharmacological therapies may also be required to control and manage hypertension, 
diabetes mellitus, hyperlipidemia and atrial fibrillation in high risk individuals.  
Additionally, medical procedures including carotid endarterectomy may be required to 
remove plaque from effected arteries14.   
Immediate treatment may minimize the effects of ischemic strokes.  The gold 
standard for treatment is the FDA approved tissue plasminogen activator (tPA).  This 
thrombolytic treatment is delivered intravenously and works by dissolving the clot to 
improve blood flow in the affected area of the brain.  The individual’s chances for 
recovery are improved if the medication is delivered within three hours and up to 4.5 
hours for certain patients.  Endovascular procedures and surgical treatments are used 
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to treat hemorrhagic strokes.  Endovascular procedures involve guiding a catheter 
from a major artery in the arm or leg and inserting a device to prevent rupture of an 
aneurysm or arteriovenous malformation (AVM).  Surgical treatment may be required 
to stop hemorrhage caused by ruptured aneurysm or AVM14.   
The acute symptoms of stroke include face drooping or numbness, arm 
hemiparesis, and speech difficulty.  Other sudden symptoms include hemiparesis or 
numbness of the leg, arm or face; confusion or trouble understanding; visual 
disturbances in one or both eyes; trouble walking, dizziness, loss of balance or 
coordination; and a severe headache with no known cause.  Diagnosis is confirmed 
through physical and neurological assessment and a computerized axial tomography 
(CT) scan or magnetic resonance imaging (MRI) of the brain14. 
Six months after stroke, nearly 50 percent of stroke survivors continue to 
experience hemiparesis and cognitive linguistic deficits and thirty percent are unable 
to walk without assistance2.  Approximately, 12 to 43 percent of stroke survivors 
experience further deterioration in mobility including walking speed and falls one to 
three years after diagnosis.  As a result, independent ambulation in the home or 
community may be compromised.  Factors affecting mobility are responsive to 
modifications in physical activity; however, are scarcely described in the literature17. 
A cross-sectional study by Vahlberg et al.17 examined the post stroke population 
to assess mobility and physical activity and their relationship to physical, 
psychological and demographic factors.  The sample included 195 community-living 
individuals age 65-85 years who had experienced a stroke in the last one to three 
years.  Mobility was measured using the SPPB and physical activity was assessed 
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using the self-reported PASE.  The performance based measures also included the 
Berg Balance Scale and 10-m walking test.  The mean SPPB score was 8.7 with a 
standard deviation of 2.9.  The mean comfortable gait speed for the 10-m walk test 
was to found to be 1.10 m/s for the cohort and 1.16 m/s and 0.94 m/s for men and 
women respectively.  The results of both performance measures were found to be 
below the results for a healthy population sample.  The findings of the study reported 
that performance based mobility was independently related to physical activity level, 
fall related self efficacy and health-related quality of life.  Likewise, physical activity 
level was related to mobility, fall related self efficacy and health-related quality of life.  
The investigators recommended future studies to evaluate the effect of actions to 
improve mobility and fall-related self efficacy on physical activity levels in the post-
stroke population17.   
Stookey et al.18 further analyzed the use the SPPB as a predictor of functional 
capacity after stroke.  Functional capacity was defined as those performance measures 
that more closely mimic the endurance and distance requirements of community 
ambulation.  Forty three participants between the age of 43 and 87 were evaluated.  
Each participant had completed conventional inpatient and outpatient physical therapy 
and was six months post ischemic stroke or 12 months post hemorrhagic stroke.  The 
measures included the SPPB total score and component results (8 foot walk, standing 
balance, chair stand); 6-minute walk; and VO2 Peak treadmill test (aerobic capacity).  
Forty participants had a total SPPB scores of less than 10; an accepted threshold for 
functional impairment.  Thirty two participants scored one or zero on the chair stand 
test.  There was a significant correlation between the SPPB and the 6-minute walk (r = 
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0.76, P < .001) and peak treadmill test (r = 0.52, p < .001).  The 6-minute walk 
relationship indicated that long distance walking capacity is captured by the SPPB.  
The participants with higher SPPB scores were also found to walk a greater distance 
the 6-m walk test.  The study results indicated that the SPPB may be reflective of 
endurance based, longer distance measures in chronic stroke patients18 although gait 
tests that involve changes of direction may be more reflection of mobility and 
community ambulation requirements. 
The relationship between gait speed and community ambulation has been reported 
in post-stroke individuals.  Perry and al.19 tested 147 stroke patients that were at least 
three months post stroke.  The investigators assessed functional walking ability 
through a walking ability questionnaire along with testing gait speed (10-m walk test), 
muscle strength, proprioception.  Gait speed was found to be the most efficient 
predictor of household or community ambulation.  Participants with an average speed 
of 0.4 m/s were predicted to have the ability for community ambulation with the 
highest category of community walking being 0.8 m/s19.  Schmid et al.20 further 
stratified gait speed into three classifications: household ambulation (<0.4 m/s), 
limited community ambulation (0.4 to 0.8 m/s) and full community ambulation (>0.8 
m/s).  They studied 64 patients that were over 50 years old and 3-28 days post-stroke 
to determine whether improvements in classification were related to clinically 
meaningful changes in function and quality of life.  The assessed gait speed using the 
10-m walk test and function and quality of life using the Stroke Impact Scale (SIS).  
Twelve of 19 household ambulators transitioned to limited community ambulation 
whereas 17 of 45 limited community ambulators became full community ambulators.  
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The function and quality of life SIS scores were significantly higher for the household 
(p = 0.0299) and limited community (p = 0.0085) participants that advanced in 
classification.  The results supported the conclusion that a gain in gait speed that 
results in a transition to a higher classification results in an improved function and 
quality of life20. 
A study of community ambulation conducted by van de Port et al.21, also 
examined the association between gait speed and community ambulation and added 
the effect of other confounding factors including age, living alone, history of falls, 
assistive walking devices, executive function, depression, fatigue, motor function, 
balance and walking endurance.  Community ambulation was characterized by four 
categories: inability to walk outside; ability to walk to the car or mailbox without 
assistance; ability to walk in the immediate outdoor environment without assistance; 
and ability to walk to stores, neighbors or activities without assistance.  The sample 
included 72 post stroke individuals with a mean age of 59 years.  The data were 
collected three years after the individual experienced the stroke.  Gait speed was 
measured in the participant’s home with the 5-m walking test.  Seventy four percent of 
the participants were identified as community walkers and 26 percent as non- or 
limited community walkers.  The average gait speed was 0.74 m/s (SD 0.30).  The 
optimal cut-off point for community ambulation of 0.66 m/s was determined using 
receiver operation characteristic curve.  Gait speed was found to be significantly 
related to community ambulation and remained the significant determinant after the 
confounders were added to the analysis.  However, several factors were noted to 
contribute to community walking ability including balance, motor function, endurance 
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and use of assistive walking devices.  Also, mobility is thought to be time-dependent 
by the investigators and may decline over time21. 
Schmid et al.22 studied individuals with chronic stroke to identify the mobility 
impairment most associated with the individual’s activity in performance of tasks or 
actions, and participation in life situations, i.e. returning to work.  The cross-sectional 
study sample consisted of 77 participants with an average age of 64 who were six 
months post stroke.  The outcome measures included gait speed (10-m walk) and 
walking capacity (6-minute walk); balance (Berg Balance Scale); balance self-efficacy 
(Activities-specific Balance Confidence); and falls self-efficacy (Modified Fall Self 
Efficacy Scale).  The gait speed for the 10-m walk was 1.33 m/s with a standard 
deviation of 1.33, relatively high for individuals with chronic stroke.  The study results 
showed a stronger correlation between balance self efficacy and post-stroke activity 
and participation (activity, r = -.544, p < .001; participation, r = -.459, p < .001; total 
activity and participation, r = -.548, p <.001) than with the physical performance 
measures of balance, gait speed and walking capacity.  There was also strong 
relationship between gait speed and activity (r = -.309, p = .006); however, gait speed 
only weakly correlated with participation or total scores22. 
A longitudinal study examining clinical determinants of deterioration in mobility 
from one to three years post-stroke was also found in the literature.  At one year post-
stroke, 264 participants aged 57 years (SD 11) were assessed.  The sample decreased 
to 205 participants at three years post-stroke with attrition attributed to withdrawals 
from the study, death and individuals lost to follow up due to relocation.  The 
independent variables included patient and stroke characteristics, physical factors 
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(Motricity Index), cognitive factors (mini mental state examination) and social factors 
(Social Support List).  The outcome variable, mobility, was assessed using the 
Rivermead Mobility Index (RMI) that consists of 14 questions and one observation.  
The RMI index score ranged from zero to 15 and a drop of > two points was 
considered deterioration in mobility.  Mobility decline was found in 21 percent of the 
participants between one and three years (p < 0.05).  Multivariate analysis showed that 
level of activity, cognitive problems, fatigue and depression were statistically 
significant predictors of mobility decline (Hosmer-Lemeshow test p > 0.05).  The 
results indicated that mobility decline is more strongly associated with psychological 
and cognitive factors rather that physical factors.  The investigators suggested that 
early recognition and treatment of these risk factors may assist in preventing 
deterioration of mobility status23.     
Each of the cross sectional studies used gait speed as a measure of physical 
function in the post stroke population.  Gait speed was reported to be the most 
efficient predictor of household and community ambulation, a significant determinant 
of community ambulation, and a powerful indicator of function and prognosis post-
stroke19, 20, 21.  An increase in gait speed was also reported to result in better function 
and quality of life20.  Gait speed was stratified into three community ambulation 
classifications: household ambulation (<0.4 m/s), limited community ambulation (0.4 
to 0.8 m/s) and full community ambulation (>0.8 m/s)19, 20.  The optimal cut-off point 
for community ambulation was later suggested to be 0.66 m/s21.  The SPPB was found 
to be reflective of endurance based, longer distance measures in chronic stroke 
patients18 and related to physical activity level, fall related self efficacy and health-
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related quality of life17.  Balance self efficacy was a behavior also found to be strongly 
correlated to post-stroke activity and participation17, 22.  Finally, a longitudinal study 
indicated that mobility decline is more strongly related with the presence of cognitive 
problems, depression and fatigue rather than physical factors23. 
 
Acquired Brain Injury – Traumatic Brain Injury   
Traumatic brain injury is caused by an external blow or jolt to the head or an 
object penetrating the skull that disrupts the normal function of the brain.  A mild TBI 
may cause a temporary dysfunction of the brain cells resulting in a brief loss of 
consciousness or change in mental status.  More severe injuries result in an extended 
loss of consciousness, memory loss or death24, 25.  The conditions caused by brain 
injury can lead to physical, cognitive, and psychosocial issues and may cause 
associated conditions including seizures, impaired reasoning, apraxia and aphasia13.  
These individuals may also experience secondary sequelae including pain, depression, 
fatigue, sedentary lifestyle and obesity13.  An estimated 5.3 million Americans or two 
percent of the population are living with a TBI related disability25. 
Traumatic brain injury occurs most often within the age groups of 0-4 years, 15-
19 years, and over 65 years of age.  Males are more likely to sustain a TBI in each of 
the age groups.  Falls are the leading cause of TBI and motor vehicle accidents are the 
leading cause of TBI deaths1.  Other leading causes of TBI include being struck by or 
against events, assaults, and sports and recreation activities.  Blasts are the leading 
cause of TBI for military personnel assigned to war zones.  Concussions and TBI 
resulting from sports and recreation activities are severely underestimated.  In a 2006 
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overview article, Langlois et al.26 estimated that 1.6 million to 3.8 million sports 
related TBIs occur each year.  Their approximation includes those TBIs where no 
medical care is sought and may be low since major injuries go unrecognized26. 
Long term treatment includes inpatient and outpatient rehabilitation to improve 
the individual’s ability to perform activities of daily living24.  Eighty-three percent of 
the individuals who suffer moderate to severe TBI will continue to demonstrate 
deficits in balance and gait after returning home impacting their activities of daily 
living and independence27.   
A study done by Peters et al.27 assessed the impact of intensive mobility training 
on balance, mobility and gait speed in individuals with chronic TBI.  Ten individuals 
aged 23.5 to 46 who were greater than three months post TBI participated in the study.  
The training was held five days per week for four weeks.  Each session lasted 150 
minutes and involved task specific training equally divided among balance, gait 
training, and strength and coordination.  Minimal detectable changes along with 
outcome measures including a 10-m walk test (gait speed) and TUG test (mobility) 
were assessed.  The MDC values for individuals with chronic stroke were substituted 
for comparison because MDC is sparsely studied for the TBI population.  Participants 
demonstrated a significant change in walking speed and mobility at the 10 session 
interim, 20 session post-test and 3 month follow up evaluations.  At the interim, post-
test and follow-up evaluations, participants also exceeded the MDC for the walking 
speed test by 70, 80, and 60 percent respectively.  There were smaller gains with the 
TUG test with 50 percent exceeding the MDC for the TUG test at post-test and 20 
percent exceeding at follow-up.  Overall, the participants demonstrated improvements 
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in walking speed, mobility and balance post-intervention.  The gait speed and mobility 
gains were also maintained at three months; however, no further evaluations were 
performed27.   
Several studies have suggested that postural instability contributes to slow gait 
speed in TBI patients28.  However, a study by Williams et al.29 found that postural 
stability did not decrease with increasing gait speed and attributed reduced gait speed 
to biomechanical deficiencies.  In the study, individuals with TBI were assessed using 
three dimensional gait analysis at self-selected (n=55) and fast walking (n=36) speeds 
over a 12 meter walkway and compared to 10 healthy control (HC) individuals that 
were speed matched to the mean TBI speeds.   When compared to the HCs, the 
individuals with TBI were found to walk with similar cadence (self-selected speed - 
TBI 99.72 (14.61) step/min, HC 97.14 (3.27); fast speed - TBI 122.28 (15.61) 
step/min, HC - 116.46 (5.68)) and step length (self-selected TBI - 0.61m (0.15) - 
0.64m (0.12), HC - 0.64m (0.03); fast speed TBI - 0.79m (0.13) – 0.82 (0.11), HC - 
0.80m (0.03)); however, their ankle power at push off was reduced (self-selected 
speed - TBI 1.30 (0.72) W/kg, HC 1.75 (0.36); fast speed - TBI 1.91 (0.86) W/kg, HC 
– 2.98 (0.32)) and hip power in early stance (self-selected speed - TBI 1.24 (0.72) 
W/kg, HC 0.58 (0.12); fast speed - TBI 2.81 (1.73) W/kg, HC – 1.14 (0.18)) and 
preswing (self-selected speed - TBI 0.92 (0.46) W/kg, HC 0.53 (0.12); fast speed - 
TBI 1.55 (0.83) W/kg, HC – 1.03 (0.27)) was increased.  They were also found to 
have a significantly (p < 0.001) increased width of the base of support (self-selected 
TBI - 0.24m (0.05), HC - 0.19m (0.02); fast speed TBI - 0.23m (0.05), HC - 0.19m 
(0.02)) and postural instability (self-selected TBI - 89.06mm (31.52), HC – 53.40mm 
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(7.06); fast speed TBI – 76.27mm (36.49), HC - 44.97mm (9.86)).  The differences 
between the groups remained constant at the fast speed and postural stability was 
unchanged with increased gait speed; however, the gait tests were performed as 
straight-line walking and no changes in direction were performed29. 
Driver et al.30 studied barriers to physical activity in individuals with traumatic 
brain injury.  A convenience sample was used for the analysis and consisted of 28 
participants aged 18 to 61 without significant cognitive impairment and enrolled in a 
comprehensive outpatient program.  A 16 item questionnaire was used to measure 
demographics, physical activity participation, barriers to physical activity, perceived 
importance of physical activity and stage of exercise change.  Additional 
questionnaires included the Behavioral Risk Factor Surveillance System (BRFSS), 
Barriers to Physical Activity Scale for People with Physical Disabilities (B-PADS) 
and Stages of Exercise Behavior Change.  The participants reported zero to nine 
barriers per individual with the female participants reporting more barriers than the 
male participants.  There were also differences in the barriers faced based on ethnicity 
and race.  The most frequently reported behaviors for the cohort included 
environmental/facility and personal barriers.  Lack of transportation and an accessible 
facility were the most frequently reported environmental/facility barriers.  Insufficient 
endurance, feeling self-conscious in a fitness center and lack of time topped the 
personal barrier list along with the participants’ disability preventing physical activity.  
The investigators also noted that the participants reported facing fewer barriers than 
reported in the literature for individuals with stroke.  The participants may have 
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perceived fewer barriers since they were only 57-90 days post injury and still involved 
in a comprehensive outpatient program30. 
In summary, gait speed was also used to assess physical function in individuals 
with TBI.  Postural stability was found to be stable with increasing gait speed and 
reduced gait speed was attributed to biomechanical deficiencies29.  Intensive mobility 
training (IMT) was found to improve balance, mobility and gait speed in individuals 
with chronic TBI.  The gait speed and mobility gains were also maintained at three 
months.  The MDC values for individuals with chronic stroke were substituted for 
comparison because MDC is sparsely studied for the TBI population27.  Finally, the 
barriers to physical activity most frequently reported by individuals with chronic TBI 
include lack of transportation, lack of an accessible facility, insufficient endurance, 
feeling self-conscious in a fitness center, lack of time along with the participants’ 
disability preventing physical activity30.  Each of the studies used a cross sectional 
design with exception of the study by Peters et al.  Peters et al.27 used an experimental 
design with a pre-test, interim test (10 sessions), post-test (20 session) and a three 
month follow up evaluation27.   
 
Conclusions 
Individuals with chronic PD, TBI and stroke face declines in balance, 
coordination, strength, mobility and overall quality of life.  Gait speed, coined the 
sixth vital sign, has been suggested to correlate with functional ability and balance 
confidence and aids in determining rehabilitation potential and fall risk.  Additionally, 
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gait speed progression has been linked to improvement in quality of life and is critical 
to maintaining community ambulation or independent mobility outside the home.  
There is limited information in the literature about longitudinal changes in gait 
speed in individuals who are in the chronic stages of Parkinson’s disease, stroke and 
traumatic brain injury.  There is even less information that jointly examines gait speed 
in PD, stroke and TBI.  The majority of studies reviewed measured gait speed using 
cross sectional analysis.  Research has yet to examine the long term status of physical 
function and gait speed across the three chronic conditions. 
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Appendix B:  Extended Methodology 
 
 
An individual’s ability to complete functional tasks can be predicted by 
examining physical performance.  Objective tests that evaluate performance include 
the SPPB, gait speed and TUG test.  The PADS provides a reliable and valid measure 
of physical activity for persons with disabilities.  Cognition has also been associated 
with physical function and can be evaluated using the RBANS. 
The SPPB was studied by Guralnik et al.1 and found to characterize older persons 
across a wide variety of functional status and predict mortality and nursing home 
admissions.  The cohort for the study was part of the Established Populations for 
Epidemiologic Studies of the Elderly (EPESE) and consisted of 5,000 adults aged 71 
or older in three communities.  The measures included using three activities to assess 
the participant’s lower extremity functioning: standing balance, 8 foot gait speed and 
repeated chair stands.  The score range for each subtest was zero to four points with a 
maximum cumulative score of 12 points.  Self-reported physical functioning included 
evaluating activities of daily living that required lower extremity function.  The results 
of the study revealed that performance on each of the tests were strongly associated 
with self-reported disability and predictive of mortality and nursing home admissions1.   
Lower extremity function is thought to be predictive of disability because it reflects 
the effects of chronic disease, comorbidities, and physiological decline that are yet to 
cause obvious disability.  A subsequent study by Guralnik et al.2 reported that 
participants with performance scores of less than 10 are more likely to have a 
disability in activities of daily living or a mobility related disability2. 
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Kwon et al.3 analyzed data from the Lifestyle Interventions and Independence for 
Elders Pilot Study (LIFE-P) to determine the magnitude of meaningful change in the 
SPPB, 4-m gait speed and 400-m walk test.  The participants were 424 sedentary 
adults aged 70-80 who scored less than 10 on the SPPB and were able to complete a 
400-m walk test in 15 minutes or less.  The individuals were also participating in a 
structured physical activity intervention of the LIFE-P study.  Participants who 
reported no difficulty or could not perform the activities were excluded from the 
study.  The investigators applied anchored and distribution based methods for self-
reported mobility to estimate minimal and substantial change in the performances 
measures over one year.  Self-reported mobility status was gathered using a Disability 
Questionnaire and provided the anchor measures.  The distribution based analysis used 
the effect size method and standard error of the measurement.  The study reported the 
best estimates for a minimally meaningful change for the SPPB total score to be 0.3 to 
0.8 points, 0.03 to 0.05 m/s for the 4-m gait speed, and 20 to 30 seconds for the 400-m 
walk test.  A range of 0.4 to 1.5 points for the SPPB, 0.08 for the 4-m gait speed, and 
50 to 60 seconds for the 400-m walk test were reported as substantial change.  The 
longitudinal format of the study was reported as a strength along with the LIFE-P 
study’s intervention increasing the participants’ potential to improve performance.  
The study limitations included the self-reported anchor measures and missing data at 
the 12-month evaluation.  The study concluded that clinically important changes in 
performance measures were consistent using several analytical techniques and the 
changes appear to be attainable in clinical trials of exercise3.   
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Gait speed alone has been suggested to correlate with functional ability and 
balance confidence and aids in determining rehabilitation potential and fall risk4.  
Additionally, gait speed progression has been linked to improvement in quality of life4, 
5.  Coined the sixth vital sign, gait speed can provide a functional perspective to health 
status similar to temperature, pulse, respirations, blood pressure and pain4.  Gait speed 
has also been identified as an important concern when determining the ability to 
ambulate outside of the home (or ambulate in the community) and distinguishing 
between limited and full community ambulation.  Examples of gait speed 
recommendations in the community include the requirement to safely cross 
intersections and crosswalks.  Andrews et al.6 studied these requirements along with 
the distance requirements for community ambulation.  Distances were measured from 
and to the closest handicapped parking place to the closest entrance and within the 
facilities at nine types of sites including supermarkets, drug stores, banks, department 
stores, post offices, medical offices, superstores, club warehouses and hardware stores.  
A total of 141 establishments in 15 cities were measured and the distances ranged 
from 52 m to 676.8 meters with the shortest distances found at post offices, banks and 
medical offices.  The longest distances were found at hardware, superstore and club 
warehouses where power scooters were available. Crosswalk distances were measured 
in four cities curb to curb for two to six lane crosswalks.  The time allotted to walk 
was recorded from the beginning of the “walk” signal to the “don’t walk” signal.  The 
time required to walk was also measured for 128 individuals (n = 32 > 65 years, n = 
96 < 65 years) crossing the intersection.  The mean gait speed used by the individuals 
was 1.32 (SD 0.31) m/s.  The mean speed required as set by the signals was 0.49 (SD 
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0.20) m/s.  The results of the study suggested that 600 m or more may be distance 
requirement for full community ambulation and found that speed requirements were 
set to accommodate the gait speed of older adults6.  
A study by Duff et al.7 reported that global cognition was related to gait speed in 
older adults with slower walkers performing worse on the cognitive measures and 
faster walkers performing better.  The study was part of the Oklahoma Longitudinal 
Assessment of Health Outcomes in Mature Adults (OKLAHOMA) Studies and the 
sample consisted of 675 community dwelling older adults aged 65 and older.  
Individuals were excluded from the study if they were unable to perform the gait 
speed test or had comorbidities that would impact cognitive functioning or gait speed 
including stroke or TIA, head injury or concussion, seizures, PD or brain hemorrhage.  
The investigators hypothesized that global cognition would be related to gait speed 
along with other cognitive domains.  Global cognition was assessed using the 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) total 
scale score7.  The RBANS consists of 12 subtests and is also used to measure 
immediate and delayed memory along with language, attention and visuospatial/ 
constructional abilities.  The delayed memory index includes four subsets (list recall, 
list recognition, story recall, and figure recall) that measure recall and recognition.  
The results can be used to assess cognitive function in individuals from 20-89 years in 
age8.  The index score results were total scale 98.2 (SD 16.1), immediate memory 95.4 
(SD 18.0), language 95.6 (SD 11.4), attention 100.2 (SD 16.1), 
visuospatial/constructional 102.9 (SD 17.7), and delayed memory 98.8 (SD 17.1).  
Gait speed was measured using a 50-foot course.  Participants were asked to walk 25 
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feet and return at their usual walking speed.  The cohort was divided into three groups 
based on gait speeds of <14 seconds, 14-17 seconds, and >17 seconds.  There were 
significant differences between the groups on age, gender and education.  Partial 
correlations, controlling for age, gender, and education, identified statistically 
significant relationships (p < .01) between gait times and the RBANS total and each of 
the component indexes7. 
The TUG test is a valid predictor of falls and mobility and measures the time in 
seconds required for an individual to rise from a chair, walk three meters, return and 
sit down in the chair9.  Whitney et al.9 studied how the TUG test could be used in 
association with the Physiological Profile Assessment (PPA) to identify individuals at 
high risk for falls.  The sample consisted of 110 adults aged 63-95 years of age who 
had fallen in the preceding 6-8 weeks.  Fall risk was determined using the PPA and the 
participants were divided in to low and high fall risk groups based on the score.  An 
Abbreviated Mental Test (AMT) was also administered to evaluate cognitive 
impairment.  The study findings suggested that the TUG test and AMT scores were 
predictive of high fall risk.  The optimal cut-point for differentiating between high and 
low fall risk of 15 seconds was determined using ROC analysis9.     
The PADS provides a reliable and valid measure of physical activity for persons 
with disabilities or chronic health conditions and has been reported to detect 
intervention related changes in physical activity10.  Rimmer et al. examined the 
psychometric properties of the PADS.  The study sample consisted of 103 adults aged 
30-70 years with disabilities and chronic health conditions.  The measures were 46 
items in three subscales: exercise, leisure time physical activity and household 
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activity.  The fitness measures included a graded exercise test and anthropometric 
measures.  The findings supported the internal consistency, reliability and ability of 
PADS to detect intervention related changes in physical activity indicating that the 
instrument is useful for monitoring baseline levels and changes in physical activity 
among persons with disabilities and chronic health conditions10. 
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Appendix C:  Consent Form for Research 
Longitudinal Study of Communication, Nutrition and Physical Activity 
 
Leslie A. Mahler, PhD, Principal Investigator 
Ingrid Lofgren, PhD, co-Investigator 
Matthew Delmonico, PhD, co-Investigator 
 
CONSENT FORM FOR RESEARCH: Participant 
Version 3: April 4, 2014 
 
The University of Rhode Island 
Department of Communicative Disorders 
25 W Independence Square, Suite I 
Kingston, RI 02881 
 
Purpose of the Consent: 
You have been invited to take part in a research project described below.  The purpose 
of the consent form you are about to read is to provide you with details about the 
research study and to inform you of your rights if you agree to participate in the study.  
Your participation is completely up to you.  The researcher will explain the project to 
you in detail.  You should feel free to ask questions.  If you have more questions later 
you can call, Dr. Leslie Mahler, the person mainly responsible for this study, at 401-
874-2490.  You may also contact Dr. Ingrid Lofgren at 401-874-5706 or Dr. Matthew 
Delmonico at 401-874-5440, who are co-Investigators on the study.  You must be at 
least 18 years old, speak English, and have neurological diagnosis of traumatic brain 
injury, stroke, or Parkinson disease to be in this research project. 
 
Description of the project: 
This is a research project designed to look at communication, nutrition, and physical 
activity characteristics of adults who have a stroke, traumatic brain injury or Parkinson 
disease.  All evaluations will be conducted at one of two University of Rhode Island 
locations; in Independence Square on the Kingston Campus at 25 West Independence 
Way, Kingston or in Independence Square at 500 Prospect Street in Pawtucket.   
 
You are being asked to be in this study because we want to determine the long-term 
impact of neurological disorders on communication, nutrition, and physical activity. 
We are looking for 200 people who have a stroke, traumatic brain injury or Parkinson 
disease to participate in this project.  Participation in this study is entirely your choice. 
 
If you decide to take part in this study, you should understand that the evaluations are 
investigational and you may not experience any benefit from participation.  
Participation may also involve additional risks as listed in the Potential Risks and 
Discomforts section. The consent form will help make sure you understand the tasks 
included in the study before you decide whether you want to take part in the study.  
You may also quit the study at any time. 
 64 
 
What will be done:  
If you agree to take part in this study, you will be asked to complete up to 11 
evaluations over five years.  Evaluations will take place every six months.  The 
evaluations will include a variety of tasks such as reading sentences and describing a 
picture, an assessment of how your muscles move, a cognitive screening, an interview, 
a clinical swallowing evaluation, and questionnaires regarding swallowing, diet and 
physical activity.  The total time for each evaluation will be approximately 3½ hours.  
All evaluations will be conducted in a quiet private room at one of the University of 
Rhode Island Speech and Hearing Clinic locations (Kingston or Pawtucket). 
 
With your permission, we will request health information from your physician about 
the following specific items only: 
 Date of diagnosis 
 Current medications 
 Imaging information about where the brain damage is located (if 
appropriate) 
 Stage of Parkinson disease (if applicable) 
You will sign a separate form to indicate whether you give your permission to 
release this health information for the study. 
 
Potential risks and discomforts: 
There are minimal foreseeable risks associated with these evaluations. There have 
been no reported adverse affects from clinical evaluation of speech and swallowing.  
There may be some unknown or unanticipated risks, but every precaution will be 
taken to ensure your personal safety.  Even though experienced personnel will obtain 
the blood samples from a finger prick, there is a chance of discomfort and minor 
bruising from the finger stick.  For physical function testing there is a risk of muscle 
soreness or other muscle injury as well as skeletal injury but we will minimize these 
risks by using standard safety practices. 
 
Purpose and benefits of the study: 
The purpose of this study is to describe communication, nutrition, and physical 
activity behaviors over time to see how they change and affect quality of life.   The 
information obtained is important because it will help us to understand how to provide 
services to meet the needs of people with neurological diagnoses.  This is an 
investigational study and there is no guaranteed benefit to your communication or 
nutrition or physical function as a result of participation in this research study.  You 
will receive personal health information such as your height and weight, physical 
function determined by a physical assessment, your blood lipids such as cholesterol 
and triglycerides.  In addition, you will receive information about your thinking skills 
and language skills and dietary choices. 
 
Drugs, devices or instruments to be used: 
Drugs will not be used in this study. The equipment for the evaluations include: 
microphone, sound level meter, tongue blade, a digital tuner, tape recorder, and video 
cameras. All equipment used to collect cognitive-linguistic and physical function data 
 65 
 
is considered non-invasive. A lancet and capillary tube will be used to obtain the blood 
sample from a finger prick and the sample will be analyzed on a small portable 
machine that is on a table. 
  
Cost to participant: 
There is no cost to you for participation in the evaluations.  Parking is available for 
free. 
 
Confidentiality: 
Your part in this study is confidential.  Your individual privacy will be maintained in 
all published and written data resulting from this study.  No names of participants will 
be published or included in written data resulting from this study.  Results of this 
study may be used for purposes of research, educational lectures, and/or professional 
presentations.  When you are entered into the study you will be assigned a code that 
does not include any identifying information.  For example, the first participant will be 
coded as Long01.  The code number will be used on all response forms and in the 
analysis of the data.   
 
Dr. Mahler and her research team will have sole access to all contact information and 
evaluation results containing your name.  This information will be kept in a locked 
filing cabinet in a locked office.  However, the U.S. Department of Health and Human 
Services, and the University of Rhode Island Institutional Review Board have the right 
to inspect all of your records relating to this research for the purpose of verifying data.  
Because of the need to release information to these parties, absolute confidentiality 
cannot be guaranteed.  Following completion of this project, contact information will 
be destroyed for those participants who wish, for any reason, not to be contacted in the 
future.  All other information will be archived and kept in a locked filing cabinet with 
the study results at the University of Rhode Island.  All research data will be retained 
for a minimum of three years following completion of the study and then will be 
destroyed.  Research data will be located in a locked filing cabinet in the principal 
investigator’s locked office. 
 
Cognitive-linguistic evaluations will be audio and video recorded to allow for data 
analyses.  At times these recordings can be useful for teaching students or 
professionals about the disorders of people with a neurological diagnosis such as 
yours.  Please indicate by signing below whether you give your permission to use your 
samples for lectures and presentations.  Audio and/or videotapes may be used for 
teaching for up to 3 years after completion of the study.  If you agree, you will never 
be identified by name in the presentations or lectures.  Your decision to give 
permission to use audio and/or video samples in lectures has no impact on your 
participation in the study. 
 
__________Yes, I give permission to use audio samples in lectures and presentations. 
 
__________Yes, I give permission to use video samples in lectures and presentations. 
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__________No, I do not want audio samples used except for research analysis. 
 
 
_____________No, I do not want video samples used except for research analysis. 
 
In case there is any injury to you during the study: 
If this study causes you any injury, you should immediately contact Dr. Leslie Mahler 
at (401) 874-2490 or contact the University of Rhode Island Speech and Hearing 
Clinic at (401) 874-5969.  You may also call the office of the Vice President for 
Research Integrity, 70 Lower College Road, University of Rhode Island, Kingston, RI 
at (401) 874-4328.  If you are injured during an evaluation or during treatment every 
effort will be made to get you medical attention but you will be responsible for paying 
for the medical treatment needed. 
 
Decision to quit at any time: 
The decision to take part in this study is up to you.  You do not have to participate.  If 
you decide to take part in the study, you may quit and stop participating in this study 
at any time. You have the right to refuse to answer any question(s) or participate in 
any procedure for any reason.  Deciding not to participate will have no effect on your 
potential to receive services from a speech-language pathologist.  If you wish to quit, 
simply inform Leslie Mahler at 874-2490 of your decision.  If you wish to pursue an 
alternative treatment instead of completing the study you will be provided with 
information on how to obtain those services. 
 
Rights and complaints: 
If you are not satisfied with the way this study is performed, you may discuss your 
complaints with Dr. Leslie Mahler (lmahler@uri.edu; 401-874-2490), Dr. Ingrid 
Lofgren (ingridlofgren@uri.edu, 401-874-5706), or Dr. Matthew Delmonico 
(delmonico@uri.edu; 401-874-5440), or you may contact the office of the Vice 
President for Research for concerns or any questions about your rights as a research 
subject at: 70 Lower College Road, University of Rhode Island, Kingston, RI at (401) 
874-4328 and speak to them anonymously if you choose. 
 
Authorization: 
Your authorization means that you have read this paper and know the purpose of the 
study and the possible risks and benefits.  It also means you know that being in this 
study is voluntary and you choose to be in this study.  You can also withdraw at any 
time.  Your questions have been answered.  Your signature on this form means that 
you understand the information and you agree to participate in this study.  
 
________________________  ________________________ 
Signature of Participant   Signature of Researcher 
 
 
_________________________  ________________________ 
Participant Typed/printed Name  Researcher Typed/printed name 
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__________________________  _______________________ 
Date      Date 
 
 
 
________________________  ________________________ 
Signature of Guardian    Signature of Researcher 
 
 
_________________________  ________________________ 
Guardian Typed/printed Name  Researcher Typed/printed name 
 
 
__________________________  _______________________ 
Date      Date 
 
 
Please sign both consent forms, keeping one for yourself. 
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Appendix D:  Short Physical Performance Battery (SPPB) 
SPPB  
 
BALANCE SCORING: 
A. Side-by-side-stand 
Held for 10 sec ❒ 1 point 
Not held for 10 sec ❒ 0 points 
Number of seconds held if less than 10 sec: ____sec 
Not attempted ❒ 0 points 
If participant did not attempt test or failed, check why: 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
If 0 points, end Balance Tests 
 
B. Semi-Tandem Stand 
Held for 10 sec ❒ 1 point 
Not held for 10 sec ❒ 0 points 
Number of seconds held if less than 10 sec: ____sec 
Not attempted ❒ 0 points 
If participant did not attempt test or failed, check why: 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
If 0 points, end Balance Tests 
 
C. Tandem Stand 
Held for 10 sec ❒ 2 points 
Held for 3 to 9.99 sec ❒ 1 point 
Held for < than 3 sec ❒ 0 points 
Not attempted ❒ 0 points 
If participant did not attempt test or failed, check why: 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
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Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
 
D. Total Balance Tests score ______ (sum points) 
Comments: 
 
GAIT SPEED TEST SCORING: 
Length of walk test course: Four meters 
 
A. Time for First Gait Speed Test (sec) 
Time for 4 meters ____sec 
If participant did not attempt test or failed, check why: 
Tried but unable ❒ 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
Aids for first walk……………None ❒Cane ❒ Other ❒ 
 
B. Time for Second Gait Speed Test 
1. Time for 4 meters ____sec 
2. If participant did not attempt test or failed, check why: 
Tried but unable ❒ 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
Aids for second walk………… None ❒ Cane ❒ Other ❒ 
 
What is the time for the faster of the two walks? ________sec. 
If the participant was unable to do the walk: ❒ 0 points 
 
For 4-Meter Walk: 
If time is more than 8.70 sec: ❒ 1 point 
If time is 6.21 to 8.70 sec: ❒ 2 points 
If time is 4.82 to 6.20 sec: ❒ 3 points 
If time is less than 4.82 sec: ❒ 4 points 
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CHAIR SCORING: 
Single Chair Stand Test: 
Safe to stand without help YES ❒ NO ❒ 
Participant stood without using arms YES ❒ NO ❒ If yes go to repeated stand 
Participant used arms to stand YES ❒ NO ❒ If yes end test; score as 0 points 
Test not completed ❒ End test; score as 0 points 
If participant did not attempt test or failed, check why: 
Tried but unable ❒ 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions ❒ 
Other (Specify) ❒ 
Participant refused ❒ 
 
Repeated Chair Stand Test 
Safe to stand five times Yes❒ No❒ If five stands completed record time 
Time to complete five stands ___sec 
If participant did not attempt test or failed, circle why: 
Tried but unable ❒ 
Participant could not walk unassisted ❒ 
Not attempted, you felt unsafe ❒ 
Not attempted, participant felt unsafe❒ 
Participant unable to understand instructions❒ 
Other (Specify) ❒ 
Participant refused ❒ 
 
Scoring the Repeated Chair Test 
Participant unable to complete 5 chair stands or completes stands in >60 sec: ❒ 0 
points 
If chair stand time is 16.70 sec or more: ❒ 1 points 
If chair stand time is 13.70 to 16.69 sec: ❒ 2 points 
If chair stand time is 11.20 to 13.69 sec: ❒ 3 points 
If chair stand time is 11.19 sec or less: ❒ 4 points 
 
Scoring for Complete Short Physical Performance Battery 
Total Balance Test score _____ points 
Gait Speed Test score _____ points 
Chair Stand Test score _____ points 
Total Score _____ points (sum of points above) 
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Appendix E:  Timed Up and Go (TUG) Test 
 
TIMED UP AND GO 
 
Time for first TUG test (sec) 
Time: ______sec 
 
If participant did not attempt test of failed, check why? 
Tried but unable___ 
Participant could not walk unassisted____ 
Not attempted, you felt unsafe____ 
Not attempted, participant felt unsafe____ 
Participant unable to understand instructions_____ 
Other (specify) _____ 
Participant refused______ 
 
Aids for first walk………….None____ Cane_____ Other_____ 
 
Time for second TUG test (sec) 
Time: ______sec 
 
If participant did not attempt test of failed, check why? 
Tried but unable___ 
Participant could not walk unassisted____ 
Not attempted, you felt unsafe____ 
Not attempted, participant felt unsafe____ 
Participant unable to understand instructions_____ 
Other (specify) _____ 
Participant refused______ 
 
Aids for second walk………….None____ Cane____ 
 
        
Page 1 of 8 
PADS Questionnaire 01.18.2006 
revised 1/11/2006 
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DEMOGRAPHICS 
NAME:______________________________ DATE: ______________ 
AGE:          ______ years 
GENDER 
  Male  
  Female 
TYPE OF DISABILITY ____________________________________ 
ASSISTIVE DEVICES (Check all that apply) 
 Walker  
 Braces  
 Cane  
 Wheelchair 
USE OF ARMS (Check one) 
 Full  
 Partial  
 No Use  
USE OF LEGS 
 Full  
 Partial  
 No Use  
 
Directions: On the following pages are a list of questions related to physical activity and 
exercise. There are no right or wrong answers and your responses will be kept anonymous. 
Note that your answers to certain questions in the survey may cause your browser to skip 
other questions and move to a later item in the survey. Don't worry--this is how the survey was 
designed in order to save time. Please answer each presented question as accurately and as 
completely as possible. When you have finished the survey, press the "Submit" button. Your 
survey responses will be checked and used to create scores reflecting your level of physical 
activity. A window presenting your scores will then appear. 
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1.  EXERCISE 
1.00  Do you currently exercise?   
 Yes      
 No 
IF NO, PLEASE GO TO THE LEISURE ACTIVITY SECTION. 
1.01  What kind of exercise do you do?   
Directions: List up to four (4) activities below that you do on a regular basis for primary 
purpose of increasing or maintaining fitness. Aerobics are done for a sustained period of 
time and result in an increase in your heart rate and breathing rate. Examples include 
walking, jogging, attending an aerobics class, and bicycling. Strength activities include 
lifting weights or using elastic bands or weight training machines. Flexibility refers to 
activities that involve muscle stretching 
Activity Type 
 
Code:  Description 
A:   Aerobic Exercise  
S:   Strength Exercise 
F:   Flexibility Exercise  
       
Activity Type 
(check one)  Activity Days/Week Minutes/Day Months/Year
 A  S  F     
 A  S  F     
 A  S  F     
 A  S  F     
 
1.02  Have you been exercising for more than one year or less than one year? 
 More than one year      
 Less than one year 
1.03  How would you describe the average intensity of your exercise program? 
 Light exercise: Don’t sweat or breathe heavily 
 Moderate exercise: Breathe a little harder and may sweat            
 Vigorous: Breathe hard and sweat 
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2. LEISURE ACTIVITY 
2.0  Do you engage in leisure time physical activity? 
 Yes      
 No 
IF NO, GO TO THE GENERAL ACTIVITY SECTION ON THE 
NEXT PAGE. 
2.1  What type of activities do you do?  
Directions: List up to four (4) activities below that you do for leisure or recreation. 
These activities can be done on a regular or irregular basis and may not necessarily 
result in sustained increases in heart rate and breathing rate. Examples include hiking, 
boating, skiing, dancing and sports activities. Please indicate whether the activity is an 
endurance activity or a Non-Endurance activity. Examples of endurance activities 
include: hiking, tennis, dancing, skiing. Non-endurance activities include boating, 
softball and horseback riding. Do not list activities here that you already listed under 
exercise. 
 
Activity Type 
 
Code   Description 
E   Endurance 
NE   Non-Endurance 
        
       
Activity Type 
(check one)  Activity Days/Week Minutes/Day Months/Year
 E  NE     
 E  NE     
 E  NE     
 E  NE     
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3. GENERAL ACTIVITY 
3.00  From Monday through Friday, how many waking hours a 
day do you usually spend inside your home?  
 Less than 6 hours a day       
 6 to 10 hours a day 
 More than 10 hours a day 
3.01  On Saturday and Sunday, how many waking hours a day do 
you usually spend inside your home?   
 Less than 6 hours a day       
 6 to 10 hours a day 
 More than 10 hours a day 
3.02  On average, how many hours a day do you sleep including 
naps? 
________________ hours 
3.03  On average, how many hours a day are you sitting or lying 
down, excluding sleeping? 
________________ hours 
3.04  Are most of your indoor household activities done by you 
or someone Else? 
 Done by you       
 Done by someone else 
IF DONE BY SOMEONE ELSE, GO TO QUESTION 3.06. 
3.05  Please list up to four (4) indoor household activities you do 
and the number of minutes a week you spend on each 
activity. 
 
Activity Minutes/Week 
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3.06  Do you do any outdoor household activities such as 
gardening?  
 Yes      
 No 
IF NO, GO TO QUESTION 3.08. 
3.07  Please list up to four (4) outdoor household activities you 
do and the number of minutes a week you spend on each 
activity. 
 
Activity Days/Week Minutes/Day Months/Year 
    
    
    
    
3.08  How much assistance do you need to perform activities of 
daily living such as dressing and bathing?  
 No assistance       
 Some assistance 
 Full assistance 
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4. THERAPY 
4.00 Do you currently receive physical or occupational therapy?  
 Yes      
 No 
IF NO, GO TO EMPLOYMENT SECTION ON THE NEXT 
PAGE. 
4.01  How many days a week do you receive therapy? 
_________  Days.  
4.02  How long does each therapy session usually last?  
__________ Minutes  
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5. EMPLOYMENT / SCHOOL 
5.00  Are you currently employed / attending school?  
 Employed      Retired 
 Not employed     Attending school 
IF UNEMPLOYED OR RETIRED, GO TO WHEELCHAIR 
SECTION ON THE NEXT PAGE. 
5.01  For most of your work / school day, do you:  
 Move around 
 Stand 
 Sit 
5.02  Do you climb any stairs during the work / school day?  
 Yes      
 No 
IF NO, GO TO QUESTION 5.04. 
5.02a  How many flights of stairs do you climb? ___________ flights 
5.02b How many times a day do you climb the stairs? __________ 
5.03  In your transportation to and from work / school, do you get 
any physical activity?  
 Yes      
 No 
IF NO PLEASE GO TO WHEELCHAIR SECTION ON THE 
NEXT PAGE. 
5.04  Please list up to four (4) employment-related physical 
activities you do and the number of minutes a week you 
spend on each activity. 
Activity Days/Week Minutes/Day Months/year 
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6. WHEELCHAIR USERS 
6.00  Do you use a wheelchair?  
 Yes      
 No 
IF NO, STOP HERE. 
6.01  How many years have you used a wheelchair? ______ years? 
6.02  During the time that you are awake, how much time do you: 
spend in your wheelchair? 
 All day  
 Most of the day  
 A few hours  
6.03  What type of wheelchair do you primarily use?  
 Manual wheelchair     
 Powered wheelchair  
IF POWERED WHEELCHAIR, STOP HERE. 
6.04  Who usually pushes your wheelchair?  
 Myself     
 Someone else  
IF SOMEONE ELSE, STOP HERE. 
6.05  On average, how many minutes a day do you push yourself 
in your wheelchair?  
 Less than 60 minutes     
 Sixty minutes or more 
 
 
 
Thank you for completing this survey! 










